Founding Organizations:

Part 1 - Incorporating the Newly Approved Therapy for MASH into Practice

Podcast

Listen On

CLDF-GHAPP Podcast Series: MASH
4 Part Series
Hosted by: Nadege Gunn, MD
With Special Guests: Elizabeth Goacher, PA, and Ann Moore, NP

Related Podcast

GHAPPcast: Recognizing the Severity of MASH

2025

Key Takeaways - Major Advancements In The Management of MASH with Parvez, Mantry, MD

2024

Part 2 - Using NITs to Identify and Manage MASH Patients

2024

What Are the Consequences of MASH Going Untreated?

2025

What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?

2025

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

2025

Part 3 - Strategies for Educating the APP Community on MASH

2024

What Is Resmetirom and How Does It Work to Treat MASH?

2025

How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?

2025

What is MASH?

2025

Rate the overall quality of this content

★ ★ ★ ★ ★

Please provide a rating for quality.

Rate the impact of this content in helping you gain/reinforce your knowledge

★ ★ ★ ★ ★

Please provide a rating for knowledge.

Rate the positive impact you believe this content can have on patient care

★ ★ ★ ★ ★

Please provide a rating for impact.